Effects of Nordic walking on health-related quality of life in overweight individuals with Type2 diabetes mellitus, impaired or normal glucose tolerance

Diabetic Medicine

Volumn 28, Issue 11, 2011, Pages 1362-1372

  Fritz, T ^a   Caidahl, K ^a   Osler, M ^a   Ostenson C G ^a   Zierath, J R ^a   Wandell P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Exercise; Heath related quality of life; Primary health care; Sleep; Walking

Indexed keywords

ADULT; ARTICLE; BASAL METABOLIC RATE; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; EXERCISE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTERVENTION STUDY; LIFESTYLE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLEEP; STRATIFIED SAMPLE; WALKING; WALKING AID;

BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OVERWEIGHT; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP; SWEDEN; TREATMENT OUTCOME; WALKING;

EID: 80054714692     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03348.x     Document Type: Article

References (31)

1. Wannamethee SG, Shaper AG, Alberti KG. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. Arch Intern Med 2000; 160: 2108-2116.
2. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type2 diabetes. Ann Intern Med 2000; 132: 605-611.
3. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793-801.
4. Sundquist K, Qvist J, Sundquist J, Johansson SE. Frequent and occasional physical activity in the elderly: a 12-year follow-up study of mortality. Am J Prev Med 2004; 27: 22-27.
5. Byberg L, Melhus H, Gedeborg R, Sundstrom J, Ahlbom A, Zethelius B et al. Total mortality after changes in leisure time physical activity in 50-year-old men: 35-year follow-up of population based cohort. Br Med J 2009; 338: b688.
6. Blair SN, Kohl HW 3rd, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. J Am Med Assoc 1995; 273: 1093-1098.
7. Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328: 538-545.
8. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
9. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
10. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
11. Arkkila PE, Gautier JF. Musculoskeletal disorders in diabetes mellitus: an update. Best Pract Res Clin Rheumatol 2003; 17: 945-970.
12. Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Ostenson CG. Psychological distress and risk of pre-diabetes and Type2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med 2008; 25: 834-842.
13. Ashworth L, Gibb I, Alberti KG. HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem 1992; 38: 1479-1482.
14. Chen KY, Bassett DR Jr. The technology of accelerometry-based activity monitors: current and future. Med Sci Sports Exerc 2005; 37: S490-S500.
15. Brorsson B, Ifver J, Hays RD. The Swedish Health-Related Quality of Life Survey (SWED-QUAL). Qual Life Res 1993; 2: 33-45.
16. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. J Am Med Assoc 1989; 262: 925-930.
17. Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 2006; 4: 70.
18. Wandell PE, Brorsson B, Aberg H. Quality of life in diabetic patients registered with primary health care services in Sweden. Scand J Prim Health Care 1997; 15: 97-102.
19. Wandell PE, Brorsson B, Aberg H. Quality of life among diabetic patients in Swedish primary health care and in the general population: comparison between 1992 and 1995. Qual Life Res 1998; 7: 751-760.
20. Wandell PE. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 2005; 23: 68-74.
21. SBU. Behandling av sömnbesvär hos vuxna - en systematisk litteraturöversikt (Treatment of insomnia in adults. A systematic literature review). Report no.199. Stockholm: The Swedish Council of Health Technology Assessment, 2010.
22. Wandell PE, Brorsson B, Aberg H. Quality of life in relation to comorbidity among diabetic patients followed for three years in Swedish primary health care. Diabetes Metab 1999; 25: 424-428.
23. Sherrill DL, Kotchou K, Quan SF. Association of physical activity and human sleep disorders. Arch Intern Med 1998; 158: 1894-1898.
24. Kubitz KA, Landers DM, Petruzzello SJ, Han M. The effects of acute and chronic exercise on sleep. A meta-analytic review. Sports Med 1996; 21: 277-291.
25. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009; 32: 491-497.
26. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type2 diabetes: a population-based study. Diabetes Care 2009; 32: 1980-1985.
27. Bjorntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and Type2 diabetes mellitus. Diabet Med 1999; 16: 373-383.
28. Han TS, Tijhuis MA, Lean ME, Seidell JC. Quality of life in relation to overweight and body fat distribution. Am J Public Health 1998; 88: 1814-1820.
29. Larsson U, Karlsson J, Sullivan M. Impact of overweight and obesity on health-related quality of life-a Swedish population study. Int J Obes Relat Metab Disord 2002; 26: 417-424.
30. Praet SF, van Rooij ES, Wijtvliet A, Boonman-de Winter LJ, Enneking T, Kuipers H et al. Brisk walking compared with an individualised medical fitness programme for patients with type2 diabetes: a randomised controlled trial. Diabetologia 2008; 51: 736-746.
31. Kallings LV, Leijon M, Hellenius ML, Stahle A. Physical activity on prescription in primary health care: a follow-up of physical activity level and quality of life. Scand J Med Sci Sports 2008; 18: 154-161.